Literature DB >> 25187138

Coexpression of molecular chaperones to enhance functional expression of anti-BNP scFv in the cytoplasm of Escherichia coli for the detection of B-type natriuretic peptide.

Bo Hee Maeng1, Dong Hyun Nam, Yong Hwan Kim.   

Abstract

Molecular chaperones are a ubiquitous family of cellular proteins that mediate the correct folding of other target polypeptides. In our previous study, the recombinant anti-BNP scFv, which has promising applications for diagnostic, prognostic, and therapeutic monitoring of heart failure, was expressed in the cytoplasm of Escherichia coli. However, when the anti-BNP scFv was expressed, 73.4% of expressed antibodies formed insoluble inclusion bodies. In this study, molecular chaperones were coexpressed with anti-BNP scFv with the goal of improving the production of functional anti-BNP in the cytoplasm of E. coli. Five sets of molecular chaperones were assessed for their effects on the production of active anti-BNP scFv. These sets included the following: trigger factor (TF); groES/groEL; groES/groEL/TF; dnaK/dnaJ/grpE; groES/groEL/dnaK/dnaJ/grpE. Of these chaperones, the coexpression of anti-BNP scFv with the groES/groEL chaperones encoded in plasmid pGro7 exhibited the most efficient functional expression of anti-BNP scFv as an active form. Coexpressed with the groES/groEL chaperones, 64.9% of the total anti-BNP scFv was produced in soluble form, which is 2.4 times higher scFv than that of anti-BNP scFv expressed without molecular chaperones, and the relative binding activity was 1.5-fold higher. The optimal concentration of L-arabinose required for induction of the groES/groEL chaperone set was determined to be 1.0 mM and relative binding activity was 3.5 times higher compared with that of no induction with L-arabinose. In addition, soluble anti-BNP scFv was increased from 11.5 to 31.4 μg/ml with optimized inducer concentration (1.0 mM L-arabinose) for the coexpression of the groES/groEL chaperones. These results demonstrate that the functional expression of anti-BNP scFv can be improved by coexpression of molecular chaperones, as molecular chaperones can identify and help to refold improperly folded anti-BNP scFv.

Entities:  

Year:  2010        PMID: 25187138     DOI: 10.1007/s11274-010-0590-5

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  23 in total

1.  Size-dependent disaggregation of stable protein aggregates by the DnaK chaperone machinery.

Authors:  S Diamant; A P Ben-Zvi; B Bukau; P Goloubinoff
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  Functional expression of single-chain variable fragment antibody against c-Met in the cytoplasm of Escherichia coli.

Authors:  Mi-Ae Heo; Su-Hyun Kim; So-Yeon Kim; Yu-Jin Kim; Junho Chung; Min-Kyu Oh; Sun-Gu Lee
Journal:  Protein Expr Purif       Date:  2005-12-28       Impact factor: 1.650

3.  Expression of an antibody fragment at high levels in the bacterial cytoplasm.

Authors:  P Martineau; P Jones; G Winter
Journal:  J Mol Biol       Date:  1998-07-03       Impact factor: 5.469

4.  Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.

Authors:  L Katherine Morrison; Alex Harrison; Padma Krishnaswamy; Radmila Kazanegra; Paul Clopton; Alan Maisel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

5.  Brain natriuretic peptide predicts mortality in the elderly.

Authors:  T Wallén; S Landahl; T Hedner; K Nakao; Y Saito
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

6.  Improvement of productivity of active horseradish peroxidase in Escherichia coli by coexpression of Dsb proteins.

Authors:  A Kondo; J Kohda; Y Endo; T Shiromizu; Y Kurokawa; K Nishihara; H Yanagi; T Yura; H Fukuda
Journal:  J Biosci Bioeng       Date:  2000       Impact factor: 2.894

7.  Procaryotic expression of single-chain variable-fragment (scFv) antibodies: secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplasmic expression in Escherichia coli.

Authors:  J F Rippmann; M Klein; C Hoischen; B Brocks; W J Rettig; J Gumpert; K Pfizenmaier; R Mattes; D Moosmayer
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

Review 8.  B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians.

Authors:  Roberto Cardarelli; Tomas G Lumicao
Journal:  J Am Board Fam Pract       Date:  2003 Jul-Aug

9.  Consortium of fold-catalyzing proteins increases soluble expression of cyclohexanone monooxygenase in recombinant Escherichia coli.

Authors:  D-H Lee; M-D Kim; W-H Lee; D-H Kweon; J-H Seo
Journal:  Appl Microbiol Biotechnol       Date:  2003-06-24       Impact factor: 4.813

10.  Secretion of a functional Fab fragment in Escherichia coli and the influence of culture conditions.

Authors:  T Shibui; K Nagahari
Journal:  Appl Microbiol Biotechnol       Date:  1992-06       Impact factor: 4.813

View more
  10 in total

Review 1.  Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.

Authors:  Jianghui Meng; Weiwei Chen; Jiafu Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

2.  Functional expression of recombinant anti-BNP scFv in methylotrophic yeast Pichia pastoris and application as a recognition molecule in electrochemical sensors.

Authors:  Bo Hee Maeng; Jeongyeon Choi; Young Seung Sa; Jae Ho Shin; Yong Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2011-09-25       Impact factor: 3.312

3.  Coexpression of molecular chaperones to enhance functional expression of anti-BNP scFv in the cytoplasm of Escherichia coli for the detection of B-type natriuretic peptide.

Authors:  Bo Hee Maeng; Dong Hyun Nam; Yong Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2010-10-20       Impact factor: 3.312

Review 4.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

5.  Comparative analysis of synthetic DNA promoters for high-level gene expression in plants.

Authors:  Dipak Kumar Sahoo; Shayan Sarkar; Sumita Raha; Indu B Maiti; Nrisingha Dey
Journal:  Planta       Date:  2014-08-05       Impact factor: 4.116

Review 6.  Effects of Environmental Factors on Soluble Expression of a Humanized Anti-TNF-α scFv Antibody in Escherichia coli.

Authors:  Mohammad Sina; Davoud Farajzadeh; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2015-11-30

7.  Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.

Authors:  Ondřej Kaplan; Jana Zárubová; Barbora Mikulová; Elena Filová; Jiřina Bártová; Lucie Bačáková; Eduard Brynda
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

8.  Soluble Expression of Humanized Anti-CD20 Single Chain Antibody in Escherichia coli by Cytoplasmic Chaperones Co-expression.

Authors:  Mohammadreza Yousefi; Safar Farajnia; Ahad Mokhtarzadeh; Bahman Akbari; Shiva Ahdi Khosroshahi; Mina Mamipour; Hassan Dariushnejad; Vahideh Ahmadzadeh
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jul-Sep

Review 9.  An overview on molecular chaperones enhancing solubility of expressed recombinant proteins with correct folding.

Authors:  Mina Mamipour; Mohammadreza Yousefi; Mohammad Hasanzadeh
Journal:  Int J Biol Macromol       Date:  2017-04-12       Impact factor: 6.953

Review 10.  Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments.

Authors:  Annamaria Sandomenico; Jwala P Sivaccumar; Menotti Ruvo
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.